GO
Loading...

Antares Pharma Inc

  • Lightning Round: Total SA, Cisco & More Wednesday, 16 Jan 2013 | 6:38 PM ET

    It’s time for the Lightning Round. Cramer makes the call on viewer favorites.

  • Lightning Round: Apple, Linn Energy and More Monday, 3 Dec 2012 | 6:04 PM ET

    Cramer makes the call on viewer favorites.

  • Oct 08- Fitch Ratings has upgraded Atrium European Real Estate Limited's Long-term Issuer Default Rating and senior unsecured rating to' BBB-' from' BB+'. The Outlook on the IDR is Stable.

  • Antares Pharma aims to raise $47M from stock sale Wednesday, 3 Oct 2012 | 2:46 PM ET

    EWING, N.J.-- Antares Pharma Inc. said Wednesday that it plans to sell 12.5 million shares of its stock for $4 per share, raising about $47 million after expenses. Shares of Antares fell 37 cents, or 8.4 percent, to $4.03 in afternoon trading Wednesday. It has traded between $1.51 and $5.58 in the last 12 months.

  • MARKET PULSE-Sarepta, HP, Leap, Ocwen, Netflix, Adtran Wednesday, 3 Oct 2012 | 1:54 PM ET

    U.S. stocks advanced on Wednesday after stronger-than-expected employment and service-sector data in the United States. But a gloomier outlook in China and Europe weighed on commodity prices and hit energy and materials shares. **SAREPTA THERAPEUTICS INC, $41.60, up 177 pct.

  • U.S. stocks rose on Wednesday after stronger-than-expected employment and service-sector data in the United States, but a gloomier outlook in China and Europe weighed on commodity prices and hit energy and materials shares. **SAREPTA THERAPEUTICS INC, $40.65, up 171 pct. **HEWLETT-PACKARD CO, $15.67, down 8.4 pct.

  • **SAREPTA THERAPEUTICS INC, $40.19, up 168 pct. **BIOLASE INC, $2.11, up 27 pct. The company said health regulators in Europe and the United States approved its laser device for use in soft tissue surgery, teeth whitening, and pain therapy.

  • The Nasdaq Composite Index rose 0.37 percent. **SAREPTA THERAPEUTICS INC, $30.30, up 102 pct. **INTERMUNE INC, $9.74, up 10 pct.

  • Oct 3- Antares Pharma Inc:. *Announces pricing of public offering of common stock. *Says public offering of 12.5 million common shares priced at $4.00 per share.

  • Antares shares fall on planned stock sale Tuesday, 2 Oct 2012 | 5:36 PM ET

    EWING, N.J.-- Shares of Antares Pharma Inc. fell more than 9 percent in after-hours trading Tuesday after the drugmaker said it plans to sell more of its stock. The company also said Tuesday that it received a $750,000 milestone payment from its partner Pfizer Inc.. Shares of Antares Pharma fell 41 cents, or 9.3 percent, to $3.99 in aftermarket trading.

  • Antares gets development payment from Pfizer Tuesday, 2 Oct 2012 | 4:54 PM ET

    EWING, N.J.-- Antares Pharma Inc. said Tuesday it received a $750,000 milestone payment from its partner Pfizer Inc.. In December 2011 Antares licensed drug delivery technology to Pfizer. Shares of Antares Pharma rose 12 cents, or 2.8 percent, to $4.40 on Tuesday.

  • Markets End Mixed As Investors Focus On Fed Monday, 29 Jan 2007 | 5:47 PM ET

    Stocks ended mixed on Monday as investors cast a wary eye on rising interest rates ahead of the Fed's two day meeting this week.

  • CNBC's Schacknow: When It's a "Big Deal" To Us Monday, 29 Jan 2007 | 1:57 PM ET

    How Big A Deal Is A Big Deal? Monday morning is traditionally the time we get the most merger and acquisition news - hence the often used (and overused) term “Merger Monday”. But how big a deal should we make over a deal? 

  • The chief executive of Symantec told CNBC that the planned $830 million acquisition of Altiris will boost the security software maker's long-term sales.